EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β1- and β2-adrenergic receptor mediated spontaneous contractions and ryanodine receptor channel opening in human failing heart

Weilan Mo, Nicole A Beard, Katherine T Gillette-Browne, Karen Hay, Elizabeth Cheesman, Alexander Dashwood, Melanie Spratt, Annalese B Semmler, Yee Weng Wong, Haris Haqqani, Derek R Laver, Torsten Christ und 2 weitere

Naunyn-Schmiedeberg's Archives of Pharmacology · 01.08.2026

DOI: 10.1007/s00210-026-05768-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 01.08.2026. Verfasst von Weilan Mo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Cardio-Vascular Molecular & Therapeutics Translational Research Group, Northside Clinical School of Medicine, University of Queensland, The Prince Ch…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Queensland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In heart failure, β-adrenergic receptor (β-AR)-Gsα-cAMP-protein kinase A (PKA) signalling predisposes to delayed-afterdepolarisation-mediated arrhythmias. Phosphodiesterases (PDEs) hydrolyse cAMP, and PDE3 restrains β 1 -AR, β 2 -AR-mediated inotropic responses in failing hearts from β-blocker-treated patients. Whether these receptors provoke arrhythmias through ryanodine receptor (RyR2) dysregulation, and how PDE activity and prior β-blockade treatment modify this, is undefined. We sought to define how β 1 -AR and β 2 -AR activation provokes arrhythmias through RyR2 mechanisms in explanted human failing hearts, and how PDE activity and prior β-blocker therapy modulate this response. A diastolic model of ventricular arrhythmia using human right ventricular trabeculae with pacing stopped was used. Trabeculae were exposed to (-)-noradrenaline/(-)-adrenaline to activate β 1 -AR/β 2 -AR respectively with or without PDE inhibitors and monitored for spontaneous contractions. In parallel, sarcoplasmic reticulum vesicles from trabeculae were used to assess RyR2 channel function, phosphorylation and oxidation. Activation of β 1 -AR or β 2 -AR increased the frequency of spontaneous contractions, concomitant increases in diastolic RyR2 channel opening, phosphorylation and oxidation. Trabeculae from carvedilol-treated patients showed fewer β 2 -AR-mediated spontaneous contractions than those treated with β 1 -AR blockers. The PDE3 inhibitor cilostamide augmented β 2 -AR-mediated spontaneous contractions, RyR2 channel opening and Ser2808 phosphorylation. In human failing heart, β 1 -AR or β 2 -AR activation increased arrhythmic contractions associated with greater diastolic RyR2 channel opening, phosphorylation and oxidation. PDE3 attenuated β 2 -AR-mediated arrhythmic contractions, RyR2 channel opening and Ser2808 hyperphosphorylation. These findings suggest that combining β 1 - and β 2 -AR blockade with strategies that reduce RyR2 Ca 2+ leak and preserve RyR2-associated PDE3 activity may improve arrhythmia control in heart failure. Graphical abstract The arrhythmogenic human failing heart. Figure shows β 1 -AR, β 2 -AR mediated arrhythmia mechanisms in human HF. Activated β 1 -AR or β 2 -AR couple to the Gsα-protein-adenylyl cyclase signalling pathway to increase cyclic AMP, activation of PKA with consequent phosphorylation of RyR2. Other changes to RyR2 include oxidation and dissociation of FKBP12.6 (Walweel et al. 2017; Denniss et al. 2020). The changes contribute to Ca 2+ leak from the sarcoplasmic reticulum through RyR2 during diastole to cause outward transport of Ca 2+ /inward transport of Na + through the Na + /Ca 2+ exchanger resulting in DAD induced action potentials, depolarization of the myocyte and arrhythmic contractions (Walweel et al. 2017; Denniss et al. 2020). The β 2 -AR pathway that mediates arrhythmia generation is under the control of PDE3 (this paper).

Schlagwörter

Stichwörter der Autor:innen

ArrhythmiaHeart failurePDE3PhosphodiesterasesRyanodine receptorβ-Blockersβ1-adrenergic receptorsβ2-adrenergic receptors

Autor:innen und Institutionen

  • Cardio-Vascular Molecular & Therapeutics Translational Research Group, Northside Clinical School of Medicine, University of Queensland, The Prince Charles Hospital, Brisbane, Australia.
  • The Division Cardiology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
  • Faculty of Science and Technology, University of Canberra, Bruce, ACT, 2617, Australia.
  • School of Clinical Sciences, Queensland University of Technology, Brisbane, Australia.
  • QIMR Berghofer Medical Research Institute, Brisbane, Qld, Australia.
  • Department of Cardiology, Heart and Lung Institute, Faculty of Medicine, The Prince Charles Hospital, The University of Queensland, Brisbane, Qld, Australia.

ORCID-Profile: Kafa Walweel

Förderung

  • The University of Queensland

Zitieren

APA

Mo, W., Beard, N. A., Gillette-Browne, K. T., Hay, K., Cheesman, E., Dashwood, A., Spratt, M., Semmler, A. B., Wong, Y. W., Haqqani, H., Laver, D. R., Christ, T., Walweel, K., & Molenaar, P. (2026). β1- and β2-adrenergic receptor mediated spontaneous contractions and ryanodine receptor channel opening in human failing heart. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05768-x

Vancouver

Mo W, Beard NA, Gillette-Browne KT, Hay K, Cheesman E, Dashwood A, et al. β1- and β2-adrenergic receptor mediated spontaneous contractions and ryanodine receptor channel opening in human failing heart. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05768-x

BibTeX
@article{Mo2026,
  author = {Mo, Weilan and Beard, Nicole A and Gillette-Browne, Katherine T and Hay, Karen and Cheesman, Elizabeth and Dashwood, Alexander and Spratt, Melanie and Semmler, Annalese B and Wong, Yee Weng and Haqqani, Haris and Laver, Derek R and Christ, Torsten and Walweel, Kafa and Molenaar, Peter},
  title = {β1- and β2-adrenergic receptor mediated spontaneous contractions and ryanodine receptor channel opening in human failing heart},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05768-x}
}
Kostenlos starten →